Evaluation of standard and enhanced quality improvement methods to increase the uptake of magnesium sulphate in pre-term deliveries for the prevention of …
HB Edwards, MT Redaniel, C Sillero-Rejon… - medRxiv, 2022 - medrxiv.org
Objective To investigate the impact of an enhanced QI support programme (ESP) in further
improving the magnesium sulphate (MgSO4) uptake compared to the National PReCePT …
improving the magnesium sulphate (MgSO4) uptake compared to the National PReCePT …
Quality improvement interventions to increase the uptake of magnesium sulphate in preterm deliveries for the prevention of cerebral palsy (PReCePT study): a cluster …
HB Edwards, MT Redaniel… - … Journal of Obstetrics …, 2024 - Wiley Online Library
Objective To compare two quality improvement (QI) interventions to improve antenatal
magnesium sulphate (MgSO4) uptake in preterm births for the prevention of cerebral palsy …
magnesium sulphate (MgSO4) uptake in preterm births for the prevention of cerebral palsy …
National PReCePT Programme: a before-and-after evaluation of the implementation of a national quality improvement programme to increase the uptake of …
HB Edwards, MT Redaniel, C Sillero-Rejon… - Archives of Disease in …, 2023 - fn.bmj.com
Objective To evaluate the effectiveness and cost-effectiveness of the National PReCePT
Programme (NPP) in increasing use of magnesium sulfate (MgSO4) in preterm births …
Programme (NPP) in increasing use of magnesium sulfate (MgSO4) in preterm births …
Evaluating an enhanced quality improvement intervention in maternity units: PReCePT trial protocol
H Edwards, MT Redaniel, B Opmeer… - BMJ open …, 2021 - bmjopenquality.bmj.com
The UK's National Institute for Health and Care Excellence Preterm labour and birth
guideline recommends use of magnesium sulfate (MgSO4) in deliveries below 30 weeks' …
guideline recommends use of magnesium sulfate (MgSO4) in deliveries below 30 weeks' …
Magnesium sulphate for fetal neuroprotection at imminent risk for preterm delivery: a systematic review with meta‐analysis and trial sequential analysis
HT Wolf, LD Huusom, TB Henriksen… - … journal of obstetrics …, 2020 - Wiley Online Library
Background Ordinary meta‐analyses indicate that magnesium sulphate (MgSO4) treatment
in women at imminent risk for preterm delivery decreases the offspring's risk of cerebral …
in women at imminent risk for preterm delivery decreases the offspring's risk of cerebral …
Impact of dosing schedule on uptake of neuroprotective magnesium sulfate
RD Cuff, SA Sullivan, EY Chang - The Journal of Maternal-Fetal & …, 2020 - Taylor & Francis
Abstract Background: Preterm delivery< 32-week gestation is associated with significant
neurodevelopmental morbidity ranging from mild delay to profound disability. Several …
neurodevelopmental morbidity ranging from mild delay to profound disability. Several …
Magnesium sulphate for fetal neuroprotection: benefits and challenges of a systematic knowledge translation project in Canada
KC Teela, DA De Silva, K Chapman, AR Synnes… - BMC Pregnancy and …, 2015 - Springer
Background Administration of magnesium sulphate (MgSO 4) to women with imminent
preterm birth at< 34 weeks is an evidence-based antenatal neuroprotective strategy to …
preterm birth at< 34 weeks is an evidence-based antenatal neuroprotective strategy to …
MAGnesium sulphate for fetal neuroprotection to prevent Cerebral Palsy (MAG-CP)—implementation of a national guideline in Canada
DA De Silva, AR Synnes, P von Dadelszen, T Lee… - Implementation …, 2018 - Springer
Background Evidence supports magnesium sulphate (MgSO4) for women at risk of imminent
birth at< 32–34 weeks to reduce the likelihood of cerebral palsy in the child. MAGnesium …
birth at< 32–34 weeks to reduce the likelihood of cerebral palsy in the child. MAGnesium …
A follow up on the feasibility after national implementation of magnesium sulfate for neuroprotection prior to preterm birth
S Hellström, A Jonsdotter, M Jonsson… - Acta Obstetricia et …, 2023 - Wiley Online Library
Introduction The risk for brain injury manifested as cerebral palsy is higher in very preterm
born children than in term. Prenatal administration of magnesium sulfate (MgSO4) has been …
born children than in term. Prenatal administration of magnesium sulfate (MgSO4) has been …
Preventing cerebral palsy in preterm labour: a multiorganisational quality improvement approach to the adoption and spread of magnesium sulphate for …
A Burhouse, C Lea, S Ray, H Bailey… - BMJ open …, 2017 - bmjopenquality.bmj.com
Magnesium sulphate has been demonstrated to be an effective neuroprotectant for babies
delivered prematurely (under 37 weeks' gestational age). Antenatal administration reduces …
delivered prematurely (under 37 weeks' gestational age). Antenatal administration reduces …